144 related articles for article (PubMed ID: 6173118)
1. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
2. Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation.
Koza I; Mardiak J; Bohunický L; Svancárová L; Fuchsberger P; Gyárfás J; Horák I; Spánik S; Sufliarsky J; Thalmeinerová Z
Neoplasma; 1992; 39(1):43-7. PubMed ID: 1382234
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
Mattsson W; Arwidi A; von Eyben F; Lindholm CE
Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
[TBL] [Abstract][Full Text] [Related]
4. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
Pitman SW; Frei E
Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
[TBL] [Abstract][Full Text] [Related]
5. 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas.
Lauria F; Baccarani M; Fiacchini M; Frezza R; Gobbi M; Tura S
Cancer Treat Rep; 1978 Aug; 62(8):1193-7. PubMed ID: 688255
[TBL] [Abstract][Full Text] [Related]
6. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
Bonadonna G; Monfardini S; Villa E
Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study.
Grozea PN; Jones SE; McKelvey EM; Coltman CA; Fisher R; Haskins CL
Cancer Treat Rep; 1979 Apr; 63(4):647-53. PubMed ID: 87277
[TBL] [Abstract][Full Text] [Related]
8. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Durant JR; Gams RA; Bartolucci AA; Dorfman RF
Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
Woods RL; Stewart J; Fox RM; Tattersall MH
Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
[TBL] [Abstract][Full Text] [Related]
10. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.
Levine AM; Wernz JC; Kaplan L; Rodman N; Cohen P; Metroka C; Bennett JM; Rarick MU; Walsh C; Kahn J
JAMA; 1991 Jul; 266(1):84-8. PubMed ID: 1710673
[TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy with methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, and bleomycin: MVP-CAB for disseminated urological cancer].
Fujii A; Morishita S; Nakamura I; Oka Y; Ohshima H; Nagata H; Iwamoto T; Itoh N; Nakagawa Y; Miyazaki S
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):55-62. PubMed ID: 1691254
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for diffuse histiocytic lymphoma that includes antimetabolites.
Cadman E; Farber L; Berd D; Bertino J
Cancer Treat Rep; 1977 Sep; 61(6):1109-16. PubMed ID: 332346
[TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
14. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Rosen G; Ghavimi F; Nirenberg A; Mosende C; Mehta BM
Cancer Treat Rep; 1977 Jul; 61(4):681-90. PubMed ID: 301781
[TBL] [Abstract][Full Text] [Related]
15. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy of advanced, diffuse, non-Hodgkin's lymphoma: results with cyclo-phosphamide, adriamycin, vincristine, prednisone, and bleomycin (CHOP-Bleo).
Case DC
J Maine Med Assoc; 1979 Sep; 70(9):348-50, 352, 368. PubMed ID: 92513
[No Abstract] [Full Text] [Related]
17. Immuno-chemotherapy of malignant lymphoma using OK-432, a streptococcal agent.
Kimura I; Ohnoshi T; Nakata Y; Takasugi K; Fujii M; Hayashi K; Kataoka M; Sato M; Nishihara R
Acta Med Okayama; 1979 Dec; 33(6):471-8. PubMed ID: 94239
[TBL] [Abstract][Full Text] [Related]
18. [Results of treatment of advanced cases of non-Hodgkin's-lymphoma (author's transl)].
Kotlarek-Haus S; Nowicka J; Gabryś K; Starzyk H; Becker M; Kaiser A; Hinrle Z
Przegl Lek; 1979; 36(7):567-71. PubMed ID: 504706
[No Abstract] [Full Text] [Related]
19. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
Parker LM; Griffiths CT; Yankee RA; Knapp RC; Canellos GP
Cancer Treat Rep; 1979 Feb; 63(2):275-9. PubMed ID: 312692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
